Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses ...

Patients with obesity can now get Zepbound’s strongest doses for a flat rate through Lilly’s self-pay pharmacy. Eli Lilly ...

Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight ... 1 medications remains prohibitively high for many. The move positions Lilly ...

With the addition of 12.5 mg and 15 mg vials, all approved doses of Zepbound will be available in single-dose vials for $499/month or less, regardless of insurance status, under Zepbound Self Pay ...

Eli Lilly launches 7.5 mg and 10 mg Zepbound vials for $499, also reducing prices for 2.5 mg and 5 mg vials. Self-pay patients can access Zepbound vials through LillyDirect, bypassing third-party ...

Frustrated Zepbound users have been advocating for vial options for some time ... “patients who are responding well to the high doses want to stay on the high doses,” he said.

Eli Lilly officials announced a new program that provides consumers with single-dose vials of the weight-loss drug Zepbound at a discount ... only help us meet the high demand for our obesity ...

Eli Lilly has introduced discounted single-dose vials of tirzepatide (Zepbound) for self-pay patients with obesity to increase accessibility. Eli Lilly responded to the high demand for tirzepatide ...